FDA Inspection 829253 — Hikma Pharmaceuticals USA, Inc.

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

The FDA completed an inspection of Hikma Pharmaceuticals USA, Inc. on Jun 7, 2013 in Eatontown, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Jun 7, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eatontown, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.